{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-10-29T12:24:22.091907+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals Remains A Buy Heading Into Q3 Earnings (VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOSlp0b1RmSnk5X2V4N2YzZkhDSmdrakxJUkVfTlU3QUtSeVFuSjRtTVhncHg3eTVydThtZXBsMnVsel9EaUZRVzFXckY0T3RtbGQ2OThLS1FPUmVTckhNOV93aVg4bElQbENZRzdtQ3ltbTVRZXVWM0tQM3o3TGQ2TnRuZ0R6NE81aWdEMmh5SU8zLV9jOWZyNEdZaXJWd3FqTVhfbA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxOSlp0b1RmSnk5X2V4N2YzZkhDSmdrakxJUkVfTlU3QUtSeVFuSjRtTVhncHg3eTVydThtZXBsMnVsel9EaUZRVzFXckY0T3RtbGQ2OThLS1FPUmVTckhNOV93aVg4bElQbENZRzdtQ3ltbTVRZXVWM0tQM3o3TGQ2TnRuZ0R6NE81aWdEMmh5SU8zLV9jOWZyNEdZaXJWd3FqTVhfbA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Remains A Buy Heading Into Q3 Earnings (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-10-28T15:59:33+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Pharmaceuticals Stock Rises 8.9% as Pipeline Progress Renews Valuation Debate - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNY0VHZXQta0Y1SXNKZThteFhwWDhQUGEyeFZvNkYtZW05UEQ1ejR3a1hWOWtSMnh6RTFtc3NDUENoc1pwaU5YS2ZwYkphVGVGc0VJaDUyU0QtemZlXzB0OXA0amhvajRQS3Z4SDR0LVBvcDdsdkpJUjQwOE1pZUlBaHFFaGdDYWh3b3c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNY0VHZXQta0Y1SXNKZThteFhwWDhQUGEyeFZvNkYtZW05UEQ1ejR3a1hWOWtSMnh6RTFtc3NDUENoc1pwaU5YS2ZwYkphVGVGc0VJaDUyU0QtemZlXzB0OXA0amhvajRQS3Z4SDR0LVBvcDdsdkpJUjQwOE1pZUlBaHFFaGdDYWh3b3c?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock Rises 8.9% as Pipeline Progress Renews Valuation Debate</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-28T16:08:38+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5\" target=\"_blank\">Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-10-27T09:43:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "H.C. Wainwright Reiterates a Buy Rating on Vertex Pharmaceuticals (VRTX) - Insider Monkey",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">H.C. Wainwright Reiterates a Buy Rating on Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
      "published": "2025-10-28T16:29:05+00:00",
      "source": "Insider Monkey"
    },
    {
      "title": "Home - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Home</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Q&A with Patti Columbe: A glimpse into her journey with Vertex’s manufactured islets - Breakthrough T1D",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNbmxvMWgwUFZrd1FhaUxXZTlUNDQyRWRqU2hZNXVLMDhTT3F4RFFGWHRmT0NMTVVmLW9ybmJQb3dTMGItWVl4RVBlbWlQQ1JvYnl1WXU5LUdUOUhadGdPeXdYZk0tcnhBcDBGaEZlOUhtcHFYd2dSM1NWSjFkUVRfUlkzajFLZUlYUllJMnpQU3dnVlBpU0tJRlhla0RNVlJXRFp3cllwbkRvQWt1SGcyTlVwc3pMN0dGM0tieWlTMA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNbmxvMWgwUFZrd1FhaUxXZTlUNDQyRWRqU2hZNXVLMDhTT3F4RFFGWHRmT0NMTVVmLW9ybmJQb3dTMGItWVl4RVBlbWlQQ1JvYnl1WXU5LUdUOUhadGdPeXdYZk0tcnhBcDBGaEZlOUhtcHFYd2dSM1NWSjFkUVRfUlkzajFLZUlYUllJMnpQU3dnVlBpU0tJRlhla0RNVlJXRFp3cllwbkRvQWt1SGcyTlVwc3pMN0dGM0tieWlTMA?oc=5\" target=\"_blank\">Q&amp;A with Patti Columbe: A glimpse into her journey with Vertex’s manufactured islets</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Breakthrough T1D</font>",
      "published": "2025-10-27T14:01:06+00:00",
      "source": "Breakthrough T1D"
    },
    {
      "title": "Vertex to Participate in the UBS Global Healthcare Conference on November 11 - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOWnBvUDVpSDdCX2Z6RWdJMmRheDNpNHRlMzJtYXAxQTVpS1M1M2ZFVmFQRW9CZkVqamU3WHFBUVpMdzJtYnhySVpoajdoQUFjWFFyMzdiTEJvVUdkZi1YNHB4OHQ3SDU0a1ZWVnlVOXhpcDRLRXB2ek1oSW02QThTTzh3VFcyUFRLTUxsSEZRUFEyNlIwYzRzTFFELVpiSU03Y2dXeU9xZGZXVG1XSVMzMzhiSTB3YTRyajRfckVTSV9ra05EdUh6N2lpT1Jxdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizgFBVV95cUxOWnBvUDVpSDdCX2Z6RWdJMmRheDNpNHRlMzJtYXAxQTVpS1M1M2ZFVmFQRW9CZkVqamU3WHFBUVpMdzJtYnhySVpoajdoQUFjWFFyMzdiTEJvVUdkZi1YNHB4OHQ3SDU0a1ZWVnlVOXhpcDRLRXB2ek1oSW02QThTTzh3VFcyUFRLTUxsSEZRUFEyNlIwYzRzTFFELVpiSU03Y2dXeU9xZGZXVG1XSVMzMzhiSTB3YTRyajRfckVTSV9ra05EdUh6N2lpT1Jxdw?oc=5\" target=\"_blank\">Vertex to Participate in the UBS Global Healthcare Conference on November 11</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-10-27T20:00:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex’s quest for a breakthrough in Type 1 diabetes - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5\" target=\"_blank\">Vertex’s quest for a breakthrough in Type 1 diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-10-08T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "product_launches": [
    {
      "title": "It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks - NAI500",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSXljRWtwSG10bXo5blQ5cmdzODU4R09Ga3hFSEg3TkdHUkd0bWxXeFdSSkZGY3lYQ0k4d05PVVpzVmZkS1phVHVNRFdpUzFWczAzRC1McVUybHhSTnRKSldkOEtPXy1wRFE2cWtzLXZPalZhN196WHdxZE15MmZ1N2Vabld3WWE3OFVNU21yWEJwMmYzWkdZVHNZcUV5YVpsUS1qd2RMZjduX1MyVTJoNXhQcG1uMGhhMV9qX0NyZm11Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSXljRWtwSG10bXo5blQ5cmdzODU4R09Ga3hFSEg3TkdHUkd0bWxXeFdSSkZGY3lYQ0k4d05PVVpzVmZkS1phVHVNRFdpUzFWczAzRC1McVUybHhSTnRKSldkOEtPXy1wRFE2cWtzLXZPalZhN196WHdxZE15MmZ1N2Vabld3WWE3OFVNU21yWEJwMmYzWkdZVHNZcUV5YVpsUS1qd2RMZjduX1MyVTJoNXhQcG1uMGhhMV9qX0NyZm11Zw?oc=5\" target=\"_blank\">It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NAI500</font>",
      "published": "2025-10-28T05:07:38+00:00",
      "source": "NAI500"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-10-28",
      "close": 422.3900146484375
    },
    "history": [
      {
        "date": "2025-10-20",
        "close": 419.1000061035156
      },
      {
        "date": "2025-10-21",
        "close": 426.2699890136719
      },
      {
        "date": "2025-10-22",
        "close": 426.44000244140625
      },
      {
        "date": "2025-10-23",
        "close": 422.6300048828125
      },
      {
        "date": "2025-10-24",
        "close": 421.3900146484375
      },
      {
        "date": "2025-10-27",
        "close": 420.1700134277344
      },
      {
        "date": "2025-10-28",
        "close": 422.3900146484375
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}